Patents by Inventor Eeva-Marja Rutanen

Eeva-Marja Rutanen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120135432
    Abstract: The invention relates to a diagnostic method for detecting susceptibility to delivery, and to a test kit for this purpose. A low, but higher than baseline level concentration of Insulin-like Growth Factor Binding Protein 1 (IGFBP-1), which is due to leakage from decidual cells, is detected by an immunological assay in a vaginal secretion sample.
    Type: Application
    Filed: February 3, 2012
    Publication date: May 31, 2012
    Applicant: Oy Medix Biochemica AB
    Inventor: Eeva-Marja RUTANEN
  • Patent number: 7892774
    Abstract: The invention relates to a diagnostic method for detecting susceptibility to delivery, and to a test kit for this purpose. A low, but higher than baseline level concentration of Insulin-like Growth Factor Binding Protein 1 (IGFBP-1), which is due to leakage from decidual cells, is detected by an immunological assay in a vaginal secretion sample.
    Type: Grant
    Filed: December 29, 2009
    Date of Patent: February 22, 2011
    Assignee: Oy Medix Biochemica AB
    Inventor: Eeva-Marja Rutanen
  • Publication number: 20100099117
    Abstract: The invention relates to a diagnostic method for detecting susceptibility to delivery, and to a test kit for this purpose. A low, but higher than baseline level concentration of Insulin-like Growth Factor Binding Protein 1 (IGFBP-1), which is due to leakage from decidual cells, is detected by an immunological assay in a vaginal secretion sample.
    Type: Application
    Filed: December 29, 2009
    Publication date: April 22, 2010
    Applicant: Oy Medix Biochemica AB
    Inventor: Eeva-Marja RUTANEN
  • Publication number: 20090269782
    Abstract: The invention relates to a diagnostic method for detecting susceptibility to delivery, and to a test kit for this purpose. A low, but higher than baseline level concentration of Insulin-like Growth Factor Binding Protein 1 (IGFBP-1), which is due to leakage from decidual cells, is detected by an immunological assay in a vaginal secretion sample.
    Type: Application
    Filed: July 7, 2009
    Publication date: October 29, 2009
    Applicant: Oy Medix Biochemica AB
    Inventor: Eeva-Marja RUTANEN
  • Publication number: 20050136490
    Abstract: The invention relates to a diagnostic method for detecting susceptibility to delivery, and to a test kit for this purpose. A low, but higher than baseline level concentration of Insulin-like Growth Factor Binding Protein 1 (IGFBP-1), which is due to leakage from decidual cells, is detected by an immunological assay in a vaginal secretion sample.
    Type: Application
    Filed: January 31, 2005
    Publication date: June 23, 2005
    Applicant: OY MEDIX BIOCHEMICA AB
    Inventor: Eeva-Marja Rutanen
  • Patent number: 5554504
    Abstract: A rapid diagnostic method for detecting the rupture of fetal membranes is disclosed. The presence of insulin-like growth factor binding protein 1 (IGFBP-1) in a vaginal secretion sample, resulting from the rupture of fetal membranes, is detected with the aid of at least one specific binding substance for IGFBP-1 .
    Type: Grant
    Filed: June 30, 1993
    Date of Patent: September 10, 1996
    Assignee: OY Medix Biochemica AB
    Inventor: Eeva-Marja Rutanen